ARTICLE | Product Development
Kate Bingham's management lessons from the vaccine frontlines of COVID-19: a BioEquity Europe interview
When working with government, Bingham says to bring an industry risk appetite and manage expectations
May 17, 2021 10:46 PM UTC
Kate Bingham brought management 101 to decision-making in leading the U.K.’s vaccine taskforce, with two top lessons for biopharmas: manage expectations, and bring an industry mindset when it comes to risk assessment.
At the special opening plenary session for the 21st Bio€quity Europe conference, former U.K. Vaccines Taskforce chairperson Kate Bingham discussed the key aspects of the collaboration between biopharma, regulators and the U.K. that led to the successful development and deployment of COVID-19 vaccines in the country, and how those ingredients can be leveraged not just for the next pandemic but to fuel faster development of therapies and vaccines for a wide variety indications...